Spark Biomedical, Inc.

About

Spark Biomedical, Inc. is a leading U.S.-based wearable neurostimulation solutions developer devoted to the life-saving work of helping 36.3 million people worldwide overcome withdrawal, heal from addiction, and achieve the better quality of life they deserve. With opioid-related misuse and overdose deaths on the rise, the company’s mission is to eliminate opioid use disorder by working to address the full lifecycle, including withdrawal management, opioid-sparing, relapse prevention, and PTSD/trauma abatement.

Spark Biomedical is helping patients take the first step of overcoming acute opioid withdrawal with its FDA-cleared wearable technology, the Sparrow Ascent— Transcutaneous Auricular Neurostimulation (tAN®) for Opioid Withdrawal Relief. Sparrow Ascent provides a safe, comfortable, drug-free treatment option supported by clinical evidence. Next steps are underway with the launch of two NIDA-funded clinical trials to improve adult relapse rates and help infants suffering from Neonatal Opioid Withdrawal Syndrome (NOWS).

For anyone trying to break the grip of opioid dependence, there have only been two options – cold-turkey or more opioids. That's why more than 80% relapse in the first month. At Spark Biomedical, we've created a wearable therapy that makes it easier for people to overcome withdrawal, heal from addiction and be free to achieve the better quality of life they deserve. We've taken the first steps by addressing opioid withdrawal and will keep pushing the bounds of science and technology to unravel the entire problem. We won't rest on a single regulatory approval or single indication. We'll remain relentless in our pursuit to defeat opioid addiction.